Amicus Therapeutics, Inc. ( FOLD) - Stock Earnings
Stock symbol FOLD is outdated, potentially delisted? Maybe it is available on other exchange?
FOLD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -24.4 million USD | 154.7 million USD |
| 2025Q3 | 17.3 million USD | 169.1 million USD |
| 2025Q4 | 1.7 million USD | 185.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
FOLD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -151.6 million USD | 399.4 million USD |
| 2024 | -56.1 million USD | 528.3 million USD |
| 2025 | -27.1 million USD | 634.2 million USD |
| 2026 Est. | — | — |
FOLD
Price: $14.49
52 week price:
Earnings Per Share: -0.09 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.4 million
Ebitda: -271.1 millionMarket Capitalization: 4.5 billion